biospecimen banks

CPDR Patient Education Program

Helpful Resources

 

Agent Orange and Prostate Cancer

Veterans diagnosed with prostate cancer may qualify for service-connected disability compensation.
Information Sheet

 

Special Clinic at WRNMMC for Men with Prostate Cancer

The Center for Prostate Disease Research (CPDR) at Walter Reed National Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".
More Information

 

Patient Education Links

American Cancer Society
Website: Cancer.Org
Phone: 800-ACS-2345

National Cancer Institute
Website: Cancer.Gov
Phone: 800-4-CANCER

National Comprehensive Cancer Network
Website: www.nccn.com

Us TOO International Prostate Cancer Education and Support Network
Website: www.ustoo.org
Phone: 800-808-7866

American Urological Association
Website: www.urologyhealth.org
Phone: 800-828-7866

Prostate Cancer Research Institute
Website: www.prostate-cancer.org
Phne: 800-641-7274

 

Newsletters

Choices
Website: www.paactusa.org
Phone: 616-453-1477

PCRI Insights
Website: www.pcri.org
Phone: 310-743-2117

The John Hopkins Prostate Bulletin
Phone: 800-829-0422

Us TOO Hotsheets
Website: www.ustoo.org

WRNMMC Us TOO Newsletter
Website: cpdr.org
Phone: 301-319-2918

CURRENT EVENTS


February 2, 2016

CPDR Urology Residents Take Top Awards at 2016 James C. Kimbrough Urological Seminar

Urology Residents conducting research at The Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center presented their research at the Residents Competition category of the James C. Kimbrough Urological Seminar, San Diego, 2016.

Read Full Article

 

January 11, 2016

A Novel Gene Alteration Associates with Aggressive Prostate Cancer in African American Men

The USU, Walter Reed-Bethesda and JPC collaborative team, through comprehensive evaluations of matched cohorts of African American and Caucasian American prostate cancers, previously established a higher frequency of ERG alterations in Caucasians (50-70%) and its significantly lower frequency in African Americans (20-25%). These intriguing observations actually provided the rational for the current study focusing on whole genome evaluations of prostate cancers from these two patient populations.

Read Full Article

 

WRNMMC UsToo! Newsletter

Read the FEBRUARY 2016 WRNMMC UsToo! Newsletter

Go to WRNMMC UsToo! Newsletter Archive